| Literature DB >> 28127417 |
Ali H El-Far1, Hamada A Ahmed2, Hazem M Shaheen3.
Abstract
The date palm (Phoenix dactylifera) seeds were utilized in some traditional medical remedies and have been investigated for their possible health benefits. This proposed study wanted to assess the effect of date palm seeds (DPS) dietary supplementation in comparison to mannan-oligosaccharides (Bio-Mos®) and β-glucan over antioxidant and immunity events that have effect on growth and carcass performances of broilers. An aggregate of 180, one-day-old, chicks were raised in the wire-floored cages and allotted into control, Bio-Mos (0.1% Bio-Mos), β-glucan (0.1% β-glucan), DPS2 (2% date crushed seeds), DPS4 (4% date crushed seeds), and DPS6 (6% date crushed seeds) groups. Broilers in DPS2 and DPS4 groups showed significant variations (P < 0.05) in relative growth rate (RGR), feed conversion ratio (FCR), and efficiency of energy utilization in comparison to control group. Moreover, all DPS fed groups showed significant increases (P < 0.05) in serum reduced glutathione (GSH) values. Meanwhile, both serum interferon-gamma (IFN-γ) and interleukin-2 (IL-2) levels were significantly increased (P < 0.05) in DPS2. Consequently, obtained data revealed a substantial enhancement of performance, immunity, and antioxidant status by DPS supplementation in broiler that might be related to the antioxidant and immune-stimulant constituents of P. dactylifera seeds.Entities:
Mesh:
Substances:
Year: 2016 PMID: 28127417 PMCID: PMC5239971 DOI: 10.1155/2016/5454963
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Ingredients percentages and calculated composition analysis of the experimental starter diets (as fed basis).
| Ingredients | Basal diet | DPS2 | DPS4 | DPS6 |
|---|---|---|---|---|
| Corn | 55 | 53.09 | 51.17 | 49.27 |
| SBM (CP 44%) | 32.04 | 32 | 32 | 32 |
| Corn gluten (CP 62%) | 5.5 | 5.6 | 5.66 | 5.7 |
| Corn oil | 3.5 | 3.39 | 3.27 | 3.17 |
| Limestone | 1.35 | 1.33 | 1.31 | 1.28 |
| Dicalcium phosphate | 1.74 | 1.74 | 1.74 | 1.74 |
| L-lysine | 0.28 | 0.28 | 0.28 | 0.27 |
| Dl-methionine | 0.14 | 0.12 | 0.12 | 0.12 |
|
| 0 | 2 | 4 | 6 |
| Vitamin and mineral premix | 0.3 | 0.3 | 0.3 | 0.3 |
| NaCl | 0.15 | 0.15 | 0.15 | 0.15 |
| Total | 100 | 100 | 100 | 100 |
| Estimated and analyzed composition | ||||
| ME | 3069.59 | 3070.39 | 3069.38 | 3070.05 |
| CP % | 22.6 | 22.6 | 22.59 | 22.58 |
| Lysine % | 1.34 | 1.34 | 1.34 | 1.34 |
| Methionine % | 0.5 | 0.5 | 0.5 | 0.5 |
| Calcium % | 1 | 1 | 1 | 1 |
| Av. (P) % | 0.45 | 0.45 | 0.45 | 0.45 |
SBM: soybean meal. ME: metabolizable energy (Kcal/kg diet). CP: crude protein. Av. (P): available phosphorous. L-lysine, 99% feed grade. Dl-methionine, 99% feed grade, China. Vitamin and mineral premix (Hero mix) produced by Hero pharm Co., Egypt.
Ingredients percentages and calculated composition analysis of the experimental finisher diets (as fed basis).
| Ingredients % | Basal diet | DPS2 | DPS4 | DPS6 |
|---|---|---|---|---|
| Corn | 67.58 | 65.54 | 63.64 | 61.55 |
| SBOM (CP 44%) | 23 | 23.09 | 23.20 | 23.35 |
| Corn gluten (CP 62%) | 3.0 | 3.0 | 3.0 | 3.0 |
| Corn oil | 3.4 | 3.36 | 3.27 | 3.17 |
| Limestone | 1.15 | 1.12 | 1.10 | 1.05 |
| Dicalcium phosphate | 1.27 | 1.30 | 1.30 | 1.30 |
| L-lysine | 0.14 | 0.13 | 0.13 | 0.12 |
| Dl-methionine | 0.01 | 0.01 | 0.01 | 0.01 |
|
| 0.0 | 2.0 | 4.0 | 6.0 |
| Vitamin and mineral premix | 0.3 | 0.3 | 0.3 | 0.3 |
| NaCl | 0.15 | 0.15 | 0.15 | 0.15 |
| Total | 100 | 100 | 100 | 100 |
| Calculated and analyzed composition | ||||
| ME | 3187.63 | 3189.41 | 3188.58 | 3188.10 |
| CP % | 18.14 | 18.13 | 18.12 | 18.14 |
| Lysine % | 0.96 | 0.96 | 0.96 | 0.96 |
| Methionine % | 0.32 | 0.32 | 0.32 | 0.32 |
| Calcium % | 0.80 | 0.80 | 0.80 | 0.80 |
| Av. (P) | 0.35 | 0.35 | 0.35 | 0.35 |
SBM: soybean meal. ME: metabolizable energy (Kcal/ kg diet). CP: crude protein. Av. (P): available phosphorous. L-lysine, 99% feed grade. Dl-methionine, 99% feed grade, China. Vitamin and mineral premix (Hero mix) produced by Hero pharm Co., Egypt.
Figure 1GC-MS chromatogram of P. dactylifera seeds methanolic extract.
GC-MS analysis of P. dactylifera seeds.
| Peak | Retention time (minutes) | Name | Area% | Molecular weight | Molecular formula |
|---|---|---|---|---|---|
| 1 | 2.47 | 1-Ethynyl-3,trans(1,1-dimethylethyl)-4,cis-methoxycyclohexan-1-ol | 1.83 | 210 | C13H22O2 |
| 2 | 3.09 | Ethanol, 2-ethoxy- | 2.77 | 90 | C4H10O2 |
| 3 | 3.82 | Pentane, 3-ethyl-2,4-dimethyl- | 2.14 | 128 | C9H2O2 |
| 4 | 4.45 |
| 8.98 | 103 | C4H9NO2 |
| 5 | 4.82 | sec-Butyl acetate | 4.48 | 116 | C6H12O2 |
| 6 | 4.94 | 4,6-Dimethyl-3-(4-methoxyphenyl) coumarin | 14.73 | 280 | C18H16O3 |
| 7 | 7.04 | cis-5,8,11,14-Eicosatetraenoic acid | 25.64 | 304 | C20H32O2 |
| 8 | 7.68 | 4-Methylcinnamic acid | 11.44 | 162 | C10H10O2 |
| 9 | 8.82 | 7-Allyloxy-4-methylcoumarin | 2.20 | 216 | C13H12O3 |
| 10 | 9.00 | Minoxidil | 8.20 | 209 | C9H15N5O |
| 11 | 9.15 | 1-(N-Methylamino)-1-phenylpropane | 2.05 | 149 | C10H15N |
| 12 | 9.52 | 2-Ethyl-2-(p-tolyl) malonamide | 2.50 | 220 | C12H16N2O2 |
| 13 | 9.81 | 6-Hydroxy-7-methoxycoumarin | 8.71 | 192 | C10H8O4 |
| 14 | 10.63 | Mesitylene | 1.91 | 120 | C9H12 |
| 15 | 13.32 | 2H-Pyran, tetrahydro-2-(12-pentadecynyloxy)- | 2.42 | 308 | C20H36O2 |
Growth performance parameters of control and treated groups.
| Group | IWT | FWT | WG | FI | FCR | RGR | PER | EEU | Mort. rate % |
|---|---|---|---|---|---|---|---|---|---|
| Control | 39.83 ± 0.55a | 2073.7 ± 52.6b | 2033.87 ± 52.09b | 3501.07 ± 0.24f | 1.75 ± 0.04ab | 192.51 ± 0.10c | 0.10 ± 0.001a | 5.46 ± 0.14ab | 8 |
| Bio-Mos | 39.91 ± 0.33a | 2204.14 ± 54.56a | 2164.23 ± 54.25a | 3550 ± 0.27a | 1.67 ± 0.05bc | 192.91 ± 0.13b | 0.03 ± 0.001b | 5.20 ± 0.14bc | 4 |
|
| 40.08 ± 0.24a | 2195.83 ± 34.26a | 2155.75 ± 34.03a | 3539.94 ± 0.28b | 1.65 ± 0.03bc | 192.9 ± 0.07b | 0.03 ± 0.001b | 5.16 ± 0.08bc | 4 |
| DPS2 | 39.96 ± 0.37a | 2290.63 ± 44.46a | 2250.67 ± 44.10a | 3519.13 ± 0.23e | 1.58 ± 0.03c | 193.19 ± 0.07a | 0.03 ± 0.001b | 4.94 ± 0.10c | 4 |
| DPS4 | 40.08 ± 0.25a | 2255.21 ± 40.60a | 2215.13 ± 40.37a | 3525.05 ± 0.20c | 1.60 ± 0.03c | 193.06 ± 0.09ab | 0.03 ± 0.001b | 5.02 ± 0.10c | 12 |
| DPS6 | 40.13 ± 0.25a | 2023.96 ± 32.5b | 1983.83 ± 32.27b | 3520 ± 0.26d | 1.78 ± 0.03a | 192.31 ± 0.08c | 0.03 ± 0.001b | 5.59 ± 0.09a | 4 |
Means within the same column carrying different letters are significantly different at P < 0.05.
Values are expressed as means ± SE.
IWT: initial body weight. FWT: final body weight. WG: weight gain. FI: feed intake. FCR: feed conversion ratio. RGR: relative growth rate. PER: protein efficiency ratio. EEU: efficiency of energy utilization.
Hemagglutination inhibition (HI) titer of Newcastle disease virus in control and treated groups at 14th, 21st, and 42nd day of age.
| Group | 14th day | 21st day | 42nd day |
|---|---|---|---|
| Control | 4.30 ± 0.06a | 5.17 ± 0.19c | 5.27 ± 0.15b |
| Bio-Mos | 4.47 ± 0.03a | 5.30 ± 0.15bc | 5.47 ± 0.03ab |
|
| 4.43 ± 0.03a | 5.20 ± 0.06c | 5.43 ± 0.03b |
| DPS2 | 4.37 ± 0.09a | 5.50 ± 0.06abc | 5.73 ± 0.15a |
| DPS4 | 4.43 ± 0.03a | 5.63 ± 0.03ab | 5.67 ± 0.09a |
| DPS6 | 4.23 ± 0.07a | 5.70 ± 0.10a | 5.63 ± 0.07a |
Means within the same column carrying different letters are significantly different at P < 0.05.
Values are expressed as means ± SE.
Dressing percentage and relative weights for liver, heart, gizzard and spleen, and thymus and bursa of control and treated groups.
| Item | Dressing % | Liver | Heart | Gizzard | Spleen | Thymus | Bursa |
|---|---|---|---|---|---|---|---|
| Control | 68% ± 0.01c | 40 ± 2.08a | 9.83 ± 0.09a | 31 ± 1.53a | 1.7 ± 0.06a | 2.83 ± 0.03c | 2.10 ± 0.06a |
| Bio-Mos | 71% ± 0.01ab | 40.67 ± 1.76a | 10.5 ± 0.29a | 34.33 ± 0.67a | 1.93 ± 0.07a | 3.20 ± 0.06a | 2.23 ± 0.07a |
|
| 72% ± 0.01a | 42 ± 1.15a | 10.67 ± 0.17a | 34.33 ± 0.67a | 1.9 ± 0.06a | 3.23 ± 0.03a | 2.23 ± 0.07a |
| DPS2 | 71% ± 0.01ab | 41.67 ± 2.03a | 10.33 ± 0.44a | 32.67 ± 2.33a | 1.83 ± 0.09a | 3.13 ± 0.07ab | 2.13 ± 0.09a |
| DPS4 | 71% ± 0.01ab | 41.67 ± 2.03a | 10.17 ± 0.6a | 31 ± 0.58a | 1.9 ± 0.06a | 2.97 ± 0.09ab | 2.20 ± 0.06a |
| DPS6 | 69% ± 0.01bc | 40.33 ± 1.86a | 10.43 ± 0.23a | 32 ± 1.0a | 1.77 ± 0.03a | 3.03 ± 0.09abc | 2.10 ± 0.06a |
Means within the same column carrying different letters are significantly different at P < 0.05.
Values are expressed as means ± SE.
The mean values of serum GSH and NO in control and treated groups.
| GSH ( | NO ( | |||
|---|---|---|---|---|
| 21st day | 42nd day | 21st day | 42nd day | |
| Control | 49.55 ± 3.29b | 23.56 ± 4.71b | 8.97 ± 0.04a | 8.24 ± 0.27bc |
| Bio-Mos | 22.31 ± 3.21c | 45.97 ± 13.56a | 8.09 ± 0.21a | 7.68 ± 0.12c |
|
| 16.75 ± 1.86d | 47.55 ± 13.59a | 8.11 ± 0.62a | 8.19 ± 0.21b |
| DPS2 | 67.44 ± 5.82a | 34.65 ± 9.42ab | 8.09 ± 0.32a | 8.07 ± 0.04ab |
| DPS4 | 55.91 ± 2.67ab | 31.71 ± 0.4ab | 8.18 ± 0.55a | 8.15 ± 0.14a |
| DPS6 | 55.46 ± 4.69ab | 34.2 ± 1.74ab | 8.17 ± 0.31a | 8.00 ± 0.09bc |
Means within the same column carrying different letters are significantly different at P < 0.05.
Values are expressed as means ± SE.
The mean values of serum IFN-γ and IL-2 in control and treated groups.
| IFN- | IL-2 (pg/mL) | |||
|---|---|---|---|---|
| 21st day | 42nd day | 21st day | 42nd day | |
| Control | 149.99 ± 34.33c | 217.02 ± 68.32c | 1.30 ± 0.55a | 1.27 ± 0.08b |
| Bio-Mos | 532.76 ± 33.16a | 373.23 ± 14.54b | 1.39 ± 0.20a | 1.86 ± 0.06ab |
|
| 314.54 ± 8.67b | 314.54 ± 8.67bc | 1.54 ± 0.25a | 1.77 ± 0.12b |
| DPS2 | 253.43 ± 56.19ab | 490.45 ± 36.16a | 1.79 ± 0.52a | 2.62 ± 0.47a |
| DPS4 | 238.19 ± 42.08ab | 431.70 ± 10.50ab | 1.61 ± 0.28a | 1.48 ± 2.20b |
| DPS6 | 437.39 ± 47.68ab | 448.23 ± 4.98ab | 1.78 ± 0.33a | 1.26 ± 0.17bc |
Means within the same column carrying different letters are significantly different at P < 0.05.
Values are expressed as means ± SE.